Immunohistochemistry and reverse transcriptase polymerase chain reaction on sentinel lymph nodes can improve the accuracy of nodal staging in breast cancer patients

International Journal of Biological Markers

Volumn 16, Issue 4, 2001, Pages 227-232

  Péley, Gábor ^a   Toth J ^a   Csuka, O ^a   Sinkovics, I ^a   Farkas, E ^a   Koves I ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

Breast cancer; Cytokeratin 20; Immunohistochemistry; Lymph node metastasis; Reverse transcriptase polymerase chain reaction; Sentinel lymph node biopsy

Indexed keywords

CYTOKERATIN 20; HEMATOXYLIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER SIZE; CANCER STAGING; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOLECULAR BIOLOGY; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

EID: 0035717035     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460080101600401     Document Type: Article

References (39)

1. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer
2. Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06: 10-year pathologic and clinical prognostic discriminants
3. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma
4. Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer?
5. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation
6. Manchester regional breast study-5 and 10 year results
7. Risk of lymphoedema following the treatment of breast cancer
8. Physical and psychological morbidity after axillary lymph node dissection for breast cancer
9. Complications of level I and II axillary dissection in the treatment of carcinoma of the breast
10. Detection and significance of occult axillary node metastases in patients with invasive breast cancer
11. Detection and significance of occult metastases in node-negative breast cancer
12. Occult axillary node metastases in breast cancer: Their detection and prognostic significance
13. Lymph node micrometastases from breast carcinoma. Reviewing the dilemma
14. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer
15. Detection of micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification
16. Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer
17. The sentinel lymph node in breast cancer. A multicenter validation study
18. Improved axillary staging of breast cancer with sentinel lymphadenectomy
19. Correspondence. Sentinel-lymph-node biopsy
20. The prognosis of small primary breast cancers
21. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma
22. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients
23. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma. A preliminary study
24. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up
25. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma. A multicentric study
26. Evaluation of axillary sentinel lymph node biopsy by immunohistochemistry and multilevel sectioning in patients with breast carcinoma
27. Pathologic analysis of sentinel lymph nodes in breast carcinoma
28. Sentinel lymph node biopsy: Strategies for pathologic examination of the specimen
29. Computer simulations of lymph node metastasis for optimizing the pathologic examination of sentinel lymph nodes in patients with breast carcinoma
30. Caution concerning micrometastatic breast carcinoma in sentinel lymph nodes
31. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node
32. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
33. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer?
34. Detection of metastatic breast cancer by β-hCG polymerase chain reaction
35. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR
36. Identification of superior markers for polymerase chain reaction of breast cancer metastases in sentinel lymph nodes
37. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
38. RT-PCR detection of breast cancer cells in sentinel lymph nodes
39. Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20